Role of Signaling Transduction Pathways in Development of Castration-Resistant Prostate Cancer

Almost all patients who succumb to prostate cancer die of metastatic castration-resistant disease. Although docetaxel is the standard treatment for this disease and is associated with modest prolongation of survival, there is an urgent need for novel treatments for castration-resistant prostate canc...

Full description

Saved in:
Bibliographic Details
Main Authors: Takahiro Inoue, Osamu Ogawa
Format: Article
Language:English
Published: Wiley 2011-01-01
Series:Prostate Cancer
Online Access:http://dx.doi.org/10.1155/2011/647987
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832556535222370304
author Takahiro Inoue
Osamu Ogawa
author_facet Takahiro Inoue
Osamu Ogawa
author_sort Takahiro Inoue
collection DOAJ
description Almost all patients who succumb to prostate cancer die of metastatic castration-resistant disease. Although docetaxel is the standard treatment for this disease and is associated with modest prolongation of survival, there is an urgent need for novel treatments for castration-resistant prostate cancer (CRPC). Great advances in our understanding of the biological and molecular mechanisms of prostate cancer progression have resulted in many clinical trials of numerous targeted therapies. In this paper, we review mechanisms of CRPC development, with particular focus on recent advances in the understanding of specific intracellular signaling pathways participating in the proliferation of CRPC cells.
format Article
id doaj-art-17162457e64147efb796453e3e2bd777
institution Kabale University
issn 2090-3111
2090-312X
language English
publishDate 2011-01-01
publisher Wiley
record_format Article
series Prostate Cancer
spelling doaj-art-17162457e64147efb796453e3e2bd7772025-02-03T05:45:08ZengWileyProstate Cancer2090-31112090-312X2011-01-01201110.1155/2011/647987647987Role of Signaling Transduction Pathways in Development of Castration-Resistant Prostate CancerTakahiro Inoue0Osamu Ogawa1Department of Urology, Graduate School of Medicine, Kyoto University, 54 Kawaharacho Shogoin, Sakyo-ku, Kyoto 606-8507, JapanDepartment of Urology, Graduate School of Medicine, Kyoto University, 54 Kawaharacho Shogoin, Sakyo-ku, Kyoto 606-8507, JapanAlmost all patients who succumb to prostate cancer die of metastatic castration-resistant disease. Although docetaxel is the standard treatment for this disease and is associated with modest prolongation of survival, there is an urgent need for novel treatments for castration-resistant prostate cancer (CRPC). Great advances in our understanding of the biological and molecular mechanisms of prostate cancer progression have resulted in many clinical trials of numerous targeted therapies. In this paper, we review mechanisms of CRPC development, with particular focus on recent advances in the understanding of specific intracellular signaling pathways participating in the proliferation of CRPC cells.http://dx.doi.org/10.1155/2011/647987
spellingShingle Takahiro Inoue
Osamu Ogawa
Role of Signaling Transduction Pathways in Development of Castration-Resistant Prostate Cancer
Prostate Cancer
title Role of Signaling Transduction Pathways in Development of Castration-Resistant Prostate Cancer
title_full Role of Signaling Transduction Pathways in Development of Castration-Resistant Prostate Cancer
title_fullStr Role of Signaling Transduction Pathways in Development of Castration-Resistant Prostate Cancer
title_full_unstemmed Role of Signaling Transduction Pathways in Development of Castration-Resistant Prostate Cancer
title_short Role of Signaling Transduction Pathways in Development of Castration-Resistant Prostate Cancer
title_sort role of signaling transduction pathways in development of castration resistant prostate cancer
url http://dx.doi.org/10.1155/2011/647987
work_keys_str_mv AT takahiroinoue roleofsignalingtransductionpathwaysindevelopmentofcastrationresistantprostatecancer
AT osamuogawa roleofsignalingtransductionpathwaysindevelopmentofcastrationresistantprostatecancer